Patient handout: Should I have ultrasound and cfDNA testing?

A recent study identified key outcomes for vasa previa diagnosis and treatment, uniting patient experiences and clinical expertise to improve future research and guidelines.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A recent study found that polycystic ovary syndrome affects uterine cell composition and gene expression, shedding light on fertility challenges and potential treatment targets.

April is STI Awareness Month, and as such, we are focusing on testing and increase of STDs in the pandemic, especially how women and minorities are affected.

A study found that a first trimester circulating microparticle biomarker can help predict spontaneous preterm birth risk, potentially improving early intervention and neonatal outcomes.

A recent study suggests that the soluble fms-like tyrosine kinase 1 to placental growth factor ratio can help predict clinical deterioration, intrapartum fetal distress, and mode of delivery, offering valuable insights for patient counseling and labor management.